How to build a reasonable long-term investment portfolio
Creating a plan and sticking to it is the key to investment success
Creating a plan and sticking to it is the key to investment success
Drug industry stock prices dropped when Donald Trump announced his intention to lower drug prices through executive decree, but in the end the markets had…
Multi-cancer early detection screenings could get coverage, once approved by FDA.
Incretin-based therapies, including GLP-1 and dual GLP-1/GIP receptor agonists, are transforming the management of type 2 diabetes, obesity, and cardiovascular risk.
Compared with fulvestrant, vepdegestrant significantly extended progression-free survival and improved response rates.
ACP and DynaMed collaborated to provide our members free access to the most current, evidence-based clinical information resource, DynaMedex. Access it here!
An existing infrastructure of teleconsulting as part of a Web-based platform was key to creating a national, real-time teleconsulting program for helping primary care providers…
The FDA is expected to decide on treatments for multiple myeloma, NSCLC, melanoma, phenylketonuria, and 2 rare kidney diseases.
Most health care leaders now believe a deadly incident is inevitable within five years, raising alarms about outdated systems, staffing shortages and limited cybersecurity preparedness…